ArticleScientific reports2025
Radiographic and clinical outcomes at 12 months following full endoscopic interlaminar decompression for grade 1 degenerative lumbar spondylolisthesis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Contralateral trans-spinous base inclined approach using AUSS for two-level lumbar lateral recess and foraminal stenosis: a case report.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lumbar spinal stenosis (LSS) frequently coexists with degenerative spondylolisthesis (DS) in the elderly population, and the standard treatment commonly involves decompression with fusion. However, fusion procedures are associated with increased morbidity and may not always be necessary, particularly in Grade I DS. Full-endoscopic unilateral laminotomy for bilateral decompression (LE-ULBD) has gained attention as a motion-preserving alternative, yet its impact on postoperative stability remains insufficiently studied. Primary objective was to evaluate 12-month improvements in patient-reported outcomes (leg-pain VAS, ODI) after LE-ULBD; radiographic stability was assessed as a key secondary endpoint. This retrospective cohort study included 32 patients with Meyerding stable Grade I DS and symptomatic LSS who underwent single-level lumbar LE-ULBD between January 2023 and October 2024. Pre- and 12-month postoperative radiographs were analyzed for segmental instability, defined as sagittal translation > 4 mm or angular motion > 10°. Clinical outcomes were assessed using Visual Analog Scale (VAS), Oswestry Disability Index (ODI), and Macnab's criteria. Subgroup analysis was performed based on slip progression. Mean vertebral slip percentage showed no significant change postoperatively (13.4% ± 3.1 vs. 13.8% ± 3.4; p = 0.27). Only one patient (3.1%) developed new radiographic instability. VAS improved from 7.1 ± 1.2 to 1.4 ± 0.8 and ODI from 64.3% ± 9.1 to 18.5% ± 4.7 (p < 0.001 for both). According to Macnab's criteria, 90.6% of patients reported Excellent or Good outcomes. Slip progression was observed in 9 patients (28.1%), but this was not associated with inferior clinical results. Complications occurred in 2/32 (6.3%) one incidental durotomy and one epidural hematoma with reoperation in 1/32 (3.1%); new radiographic instability in 1/32 (3.1%). LE-ULBD appears to be a safe and effective treatment option for selected patients with Grade I DS and LSS, achieving significant symptomatic relief while preserving segmental stability in the majority of cases. These findings support its consideration as an alternative to fusion in carefully selected individuals. LE-ULBD short-term (12-month) radiographic stability and clinically meaningful improvement in patients with stable grade-I degenerative spondylolisthesis; longer-term follow-up is required to determine durability and late instability risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.